Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma

Shamzah Araf; Koorosh Korfi; Findlay Bewicke-Copley; Jun Wang; Sergio Cogliatti; Emil Kumar; Flavio Forrer; Sally F. Barrington; Trevor A. Graham; David W. Scott; Lisa M. Rimsza; Andrew Davies; Peter Johnson; Jessica Okosun; Jude Fitzgibbon; Martin Fehr

doi:10.3324/haematol.2019.242206

Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma

Shamzah Araf, Koorosh Korfi, Findlay Bewicke-Copley, Jun Wang, Sergio Cogliatti, Emil Kumar, Flavio Forrer, Sally F. Barrington, Trevor A. Graham, David W. Scott, Lisa M. Rimsza, Andrew Davies, Peter Johnson, Jessica Okosun, Jude Fitzgibbon, Martin Fehr

Laboratory Medicine and Pathology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	E318-E321
Journal	Haematologica
Volume	105
Issue number	6
DOIs	https://doi.org/10.3324/haematol.2019.242206
State	Published - Jun 1 2020

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2019.242206

Cite this

Araf, S., Korfi, K., Bewicke-Copley, F., Wang, J., Cogliatti, S., Kumar, E., Forrer, F., Barrington, S. F., Graham, T. A., Scott, D. W., Rimsza, L. M., Davies, A., Johnson, P., Okosun, J., Fitzgibbon, J., & Fehr, M. (2020). Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma. Haematologica, 105(6), E318-E321. https://doi.org/10.3324/haematol.2019.242206

Araf, S, Korfi, K, Bewicke-Copley, F, Wang, J, Cogliatti, S, Kumar, E, Forrer, F, Barrington, SF, Graham, TA, Scott, DW, Rimsza, LM, Davies, A, Johnson, P, Okosun, J, Fitzgibbon, J & Fehr, M 2020, 'Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma', Haematologica, vol. 105, no. 6, pp. E318-E321. https://doi.org/10.3324/haematol.2019.242206

@article{a63352867d524866bf50970f5b7e0bc1,

title = "Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma",

author = "Shamzah Araf and Koorosh Korfi and Findlay Bewicke-Copley and Jun Wang and Sergio Cogliatti and Emil Kumar and Flavio Forrer and Barrington, {Sally F.} and Graham, {Trevor A.} and Scott, {David W.} and Rimsza, {Lisa M.} and Andrew Davies and Peter Johnson and Jessica Okosun and Jude Fitzgibbon and Martin Fehr",

note = "Funding Information: 1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; 2Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; 3Institute of Pathology, Cantonal Hospital St Gallen, St Gallen, Switzerland; 4Department of Nuclear Medicine, Cantonal Hospital St Gallen, St Gallen, Switzerland; 5King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK; 6Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK; 7Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada; 8Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA; 9Cancer Research UK Centre, University of Southampton, Southampton, UK and 10Clinic for Medical Oncology and Haematology, Cantonal Hospital St Gallen, St Gallen, Switzerland Funding: this work was supported by grants from Cancer Research UK (15968 awarded to JF, Clinical Research Fellowship awarded to SA) and Bloodwise through funding of the Precision Medicine for Aggressive Lymphoma (PMAL) consortium (15002). SFB acknowledges support from the National Institute for Health Research and Social Care (NIHR) [RP-2-16-07-001]. King{\textquoteright}s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Correspondence: SHAMZAH ARAF - s.araf@qmul.ac.uk JUDE FITZGIBBON - j.fitzgibbon@qmul.ac.uk doi:10.3324/haematol.2019.242206 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2020",

month = jun,

day = "1",

doi = "10.3324/haematol.2019.242206",

language = "English (US)",

volume = "105",

pages = "E318--E321",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "6",

}

TY - JOUR

T1 - Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma

AU - Araf, Shamzah

AU - Korfi, Koorosh

AU - Bewicke-Copley, Findlay

AU - Wang, Jun

AU - Cogliatti, Sergio

AU - Kumar, Emil

AU - Forrer, Flavio

AU - Barrington, Sally F.

AU - Graham, Trevor A.

AU - Scott, David W.

AU - Rimsza, Lisa M.

AU - Davies, Andrew

AU - Johnson, Peter

AU - Okosun, Jessica

AU - Fitzgibbon, Jude

AU - Fehr, Martin

N1 - Funding Information: 1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; 2Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; 3Institute of Pathology, Cantonal Hospital St Gallen, St Gallen, Switzerland; 4Department of Nuclear Medicine, Cantonal Hospital St Gallen, St Gallen, Switzerland; 5King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK; 6Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK; 7Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada; 8Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA; 9Cancer Research UK Centre, University of Southampton, Southampton, UK and 10Clinic for Medical Oncology and Haematology, Cantonal Hospital St Gallen, St Gallen, Switzerland Funding: this work was supported by grants from Cancer Research UK (15968 awarded to JF, Clinical Research Fellowship awarded to SA) and Bloodwise through funding of the Precision Medicine for Aggressive Lymphoma (PMAL) consortium (15002). SFB acknowledges support from the National Institute for Health Research and Social Care (NIHR) [RP-2-16-07-001]. King’s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Correspondence: SHAMZAH ARAF - s.araf@qmul.ac.uk JUDE FITZGIBBON - j.fitzgibbon@qmul.ac.uk doi:10.3324/haematol.2019.242206 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85085677964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085677964&partnerID=8YFLogxK

U2 - 10.3324/haematol.2019.242206

DO - 10.3324/haematol.2019.242206

M3 - Letter

C2 - 32273479

AN - SCOPUS:85085677964

SN - 0390-6078

VL - 105

SP - E318-E321

JO - Haematologica

JF - Haematologica

IS - 6

ER -

Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this